Adverse events and β-lactam trough plasma concentrations during the treatment of endocarditis

被引：0
|
作者：
Tattevin, P. [1 ]
Tribut, O. [1 ]
Polard, E. [1 ]
Gouaillier, F. [1 ]
Mercier, M. [1 ]
Kervegant, C. [1 ]
Chapplain, J. M. [1 ]
Arvieux, C. [1 ]
Michelet, C. [1 ]
机构：
[1] Pontchaillou Univ Hosp, Rennes, France
来源：
CLINICAL RESEARCH IN CARDIOLOGY | 2007年 / 96卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：427 / 427
页数：1
相关论文
共 50 条
  • [31] Plasma trough concentrations of antihypertensive drugs for the assessment of treatment adherence: a meta-analysis
    Groenland, E. H.
    van Kleef, M. E. A. M.
    Bots, M. L.
    Visseren, F. L. J.
    Van Maarseveen, E. M.
    Spiering, W.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2776 - 2776
  • [32] High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatment
    Lind, Marcus
    Jansson, Jan-Hakan
    Nilsson, Torbjorn K.
    Johansson, Lars
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (12) : 1981 - 1986
  • [33] Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence A Meta-Analysis
    Groenland, Eline H.
    van Kleef, Monique E. A. M.
    Bots, Michiel L.
    Visseren, Frank L. J.
    van der Elst, Kim C. M.
    Spiering, Wilko
    HYPERTENSION, 2021, 77 (01) : 85 - 93
  • [34] Trough dabrafenib plasma concentrations can predict occurrence of adverse effects requiring dose reduction in metastatic melanoma
    Rousset, M.
    Dutriaux, C.
    Bosco-Levy, P.
    Prey, S.
    Pham-Ledard, A.
    Dousset, L.
    Gerard, E.
    Bouchet, S.
    Canal-Raffin, M.
    Titier, K.
    Molimard, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 32 - 32
  • [35] Adverse events related to intravenous antibiotic therapy: a prospective observational study in the treatment of infective endocarditis
    Goncalves De Paula, Debora Holanda
    Tura, Bernardo Rangel
    Lamas, Cristiane da Cruz
    BMJ OPEN, 2012, 2 (05):
  • [36] Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
    Shin, Hong-Joon
    Yoon, Joon-Young
    Na, Young-Ok
    Lee, Jae-Kyeong
    Kho, Bo Gun
    Kim, Tae-Ok
    Kim, Yu-Il
    Lim, Sung-Chul
    Jeong, Sae-Hee
    Kwon, Yong-Soo
    PLOS ONE, 2023, 18 (11):
  • [37] Major Adverse Cardiovascular Events and Hyperuricemia During Treatment of Tuberculosis
    Shin, H.
    Chang, J.
    Kim, T.
    Kim, Y.
    Kwon, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [38] High anti-tumor necrosis factor alpha treatment trough concentrations are not associated with higher rate of adverse events in pediatric patients with inflammatory bowel disease
    Zvuloni, M.
    Matar, M.
    Levi, R.
    Shamir, R.
    Assa, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S395 - S395
  • [39] Diagnostic challenges of respiratory adverse events during everolimus treatment
    Willemsen, Annelieke E. C. A. B.
    De Vos, Filip Y.
    Jansen, Anne
    de Boer, Maaike
    Tjan-Heijnen, Vivianne C. G.
    van Herpen, Carla M. L.
    TARGETED ONCOLOGY, 2014, 9 (03) : 287 - 291
  • [40] Adverse events during radiofrequency treatment of 582 hepatic tumors
    de Baère, T
    Risse, O
    Kuoch, V
    Dromain, C
    Sengel, C
    Smayra, T
    El Din, MG
    Letoublon, C
    Elias, D
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (03) : 695 - 700
12345